Welcome to the T-Cell Engager Therapeutics Blog
Click to explore all of our content related to the 2026 event.
Speaker Interview: Nathaniel Davies from T-Cypher Bio
We caught up with one of the researchers joining the 8th T‑Cell Engager Therapeutics Summit to learn more about their work.
Speaker Interview: Jack Silberstein from Deck Bio
8th T-Cell Engager Therapeutics Summit: Hear From an Expert Speaker Taking the Stage at this Years Summit
Industry News: $1.71B Vir–Astellas Partnership Announced
A major new partnership between Vir and Astellas boosts development of next‑generation PSMA‑targeting TCEs.
Explore the Brand-New Agenda
Hear the latest industry breakthroughs in T-Cell Engager development and gain exclusive modality and platform insights during our packed agenda.
Partner With Us
Position yourself as the go-to service provider of the rapidly progressing T-Cell Engager landscape to ensure your brand is at the heart of deals in this evolving space.
Join Biopharma Experts
Be part of the most critical conversations shaping the future of solid tumor and autoimmune therapy, where you can connect with like-minded experts across every stage of drug development.